Biogen Inc. buy Truist Financial Co.
Start price
16.05.24
/
50%
€210.90
Target price
16.05.25
€312.83
Performance (%)
-45.71%
End price
17.05.25
€114.50
Summary
This prediction ended on 17.05.25 with a price of €114.50. The BUY prediction by Truist_Financial_Co_ for Biogen Inc. performed very badly with a performance of -45.71%. Truist_Financial_Co_ has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 2.181% | 2.181% | 60.249% |
| iShares Core DAX® | 2.573% | 5.333% | 8.273% |
| iShares Nasdaq 100 | 4.858% | 0.449% | 27.079% |
| iShares Nikkei 225® | 5.590% | -0.586% | 48.553% |
| iShares S&P 500 | 3.250% | 2.500% | 23.351% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $340.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten